Id |
Subject |
Object |
Predicate |
Lexical cue |
T221 |
0-139 |
Sentence |
denotes |
The position of SA O-acetylation is linked to functions including substrate differentiation of enzymes such as NAs and esterase by C4 O-Ac. |
T222 |
140-269 |
Sentence |
denotes |
Previous development of O-Ac site-selective NA inhibitors were based on the conceptual consideration of different O-Ac positions. |
T223 |
270-378 |
Sentence |
denotes |
The O-Ac of SAs is site-specific, as C4 of Neu5Ac is considered to be a potential position for modification. |
T224 |
379-487 |
Sentence |
denotes |
Historically, inhibitors of influenza A and B viruses-sialidases were designed by Von-Itzstein in 1993 [39]. |
T225 |
488-597 |
Sentence |
denotes |
The Ac group-based C4 substitution interacts with amino acid Glu-119 present in the active site of sialidase. |
T226 |
598-767 |
Sentence |
denotes |
Guanidine-attached C4 of C2–C3 unsaturated SA (Neu5Ac2en) inhibits activity of sialidases isolated from influenza A virus (Singapore/1/57) and B virus (Victoria/102/85). |
T227 |
768-902 |
Sentence |
denotes |
The same scenario was applied for sialidase inhibition of the human parainfluenza virus type 3, which has HN and fusion proteins [40]. |
T228 |
903-981 |
Sentence |
denotes |
The C4 of Neu5Ac2en was substituted by alkyl groups such as the O-ethyl group. |
T229 |
982-1071 |
Sentence |
denotes |
For example, Zanamivir has a substitution with a 4-guanidino group with an IC50 of 25 μM. |
T230 |
1072-1145 |
Sentence |
denotes |
Thus, sialidase inhibition is important for C4 modification of Neu5Ac2en. |
T231 |
1146-1289 |
Sentence |
denotes |
Later, oseltamivir with the tradename Tamiflu (Basel, Switzerland) and zanamivir with the tradename Relenza (London, UK) were established [41]. |
T232 |
1290-1363 |
Sentence |
denotes |
These drugs exhibit some adverse side effects that restrict clinical use. |